Article Text

PDF
Gonadotrophin releasing hormone analogues for advanced prostate cancer

Abstract

When we last reviewed the management of metastatic prostate cancer in 19861 we concluded that orchidectomy was the treatment of choice. At that time little was known about the place of gonadotrophin releasing hormone (GnRH) analogues, but now they are widely used. Do they represent an advance in the management of late-stage disease?

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.